Moonlake Immunotherapeutics
Ticker: MLTX
| Insider | Title |
|---|---|
| Andrew John Phillips | Director |
| Asset Management, Lp Cormorant | 10% or greater ownership |
| Bihua Chen | 10% or greater ownership |
| Catherine Moukheibir | Director |
| Da Silva Jorge Santos | Chief Executive Officer, Director |
| Global Healthcare Master Fund, Lp Cormorant | 10% or greater ownership |
| Gp Holdings Llc Bvf | Director, 10% or greater ownership |
| Holdings Llc Helix | Former 10% Holder |
| I Gp Llc Bvf | Director, 10% or greater ownership |
| Ii Gp Llc Bvf | Director, 10% or greater ownership |
| Inc/il Bvf | Director, 10% or greater ownership |
| Kara Lassen | Director |
| Kristian Reich | Chief Scientific Officer |
| Mark N Lampert | Director, 10% or greater ownership |
| Matthias Bodenstedt | Chief Financial Officer |
| Partners L P/il Bvf | Director, 10% or greater ownership |
| Partners Os Ltd. Bvf | Director, See Explanation of Responses |
| Private Healthcare Fund Ii, Lp Cormorant | 10% or greater ownership |
| Private Healthcare Fund Iii Lp Cormorant | 10% or greater ownership |
| Private Healthcare Fund Iv Lp Cormorant | 10% or greater ownership |
| Ramnik Xavier | Director |
| Simon Sturge | Director |
| Spike Loy | Director |
| Value Fund Ii Lp Biotechnology | Director, 10% or greater ownership |
| Value Fund L P Biotechnology | Director, 10% or greater ownership |
| Value Trading Fund Os Lp Biotechnology | Director, See Explanation of Responses |